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The Editorial on the Research Topic 
Brief Interventions for Risky Drinkers 
Alcohol consumption is a wholly or contributory cause for more than 200 diseases, injuries, and other 
health conditions with three-digit ICD-10 codes (1). Globally, alcohol is the fifth most important risk 
factor for ill-health and premature death (2). Risky alcohol use can be defined as a quantity or pattern 
of alcohol use that places individuals at risk for adverse health and social outcomes (3). Harmful use, 
in turn, can be defined as alcohol use that results in physical, psychological, or social harm (3). Using 
a threshold of an average of 60 g of alcohol/day for a man and 40 g/day for a woman (4), about one 
in four Europeans aged 15–64 years use alcohol in a risky fashion (5). And, using a threshold of an 
average of 100 g of alcohol/day for a man and 60 g/day for a woman, about one in eight of Europeans 
aged 15–64 years use alcohol in a harmful fashion (5). Harmful use causes comorbid illnesses such 
as liver disease, depression, and raised blood pressure (6). Risky and harmful alcohol use and their 
comorbid illnesses are frequently detected in primary health care, emergency departments, and other 
non-specialized clinical settings. Brief advice emerged in the 1980s (7–9) and progressed during the 
three following decades as a strategy to reduce risky and harmful alcohol use in non-specialized 
clinical settings (10). This article provides an update of the state-of-the art of brief advice.
EFFiCaCY aNd EFFECtiVENESS oF BriEF adViCE
Twenty-four systematic reviews have demonstrated the efficacy and effectiveness of brief advice 
delivered in primary health care settings to reduce risky and harmful alcohol use [O’Donnell et al.; 
(11, 12)]. The negative results found in some studies can be explained by several misconceptions 
about null findings and should not diminish the strength of the evidence base for the efficacy and 
effectiveness of brief advice (Heather). Examples of misconceptions include difficulties in distin-
guishing between “evidence of absence and absence of evidence” and the interference of reduction 
in consumption in control groups from baseline to follow-up mediated by regression to the mean, a 
research participation effect, or assessment reactivity.
WHY doES BriEF adViCE WorK?
The underlying mechanisms of the effectiveness of brief advice are only partially known (Gaume 
et al.). Personalized feedback seems an effective ingredient. Other components (including advice 
to reduce/stop drinking, presenting alternative change options, moderation strategies, changes 
in norms perception, discrepancy between current behavior and goals/values, and change plan 
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exercises) appear to be promising. Change talk seems to acts as a 
mediator of brief advice, whereas readiness to change seems an 
inconsistent mediator of the effectiveness of brief advice. More 
research on other potential active ingredients is needed, such as 
the perceived risk/benefit of alcohol intake, alcohol treatment 
seeking, self-efficacy, or enhanced awareness.
For WHoM CaN BriEF adViCE HElP?
Brief advice seems to work in primary health care and, in emer-
gency departments, for men without other drug use (Wojnar and 
Jakubczyk). Brief advice does not seem to work for men seen in 
emergency departments as a consequence of violence-related 
events, or for women as a whole seen in emergency departments. 
In general, the effectiveness of brief advice in primary health care 
for women remains limited (11). Research on the effectiveness 
of brief advice in social service settings and at the workplace 
is understudied, and no conclusions of its impact can be made 
(Schulte et al.). Data on the efficacy of brief advice for illegal drug 
users are lacking for a number of reasons: concomitant unhealthy 
alcohol use, comorbid mental health conditions, variety of drugs 
used, and a wide range in severity (Saitz). In conclusion, there 
is insufficient evidence to support the implementation of brief 
advice in settings other than primary health care or for drugs. 
Further research is needed in these areas.
iMPlEMENtatioN BarriErS
Although the cost-effectiveness of brief advice is well-established 
(Angus et al.), it has not proved a sufficient trigger for the wide-
spread implementation of brief advice in clinical practice, even 
though key stakeholders in several European health systems 
(for example, Catalonia, England, Finland, Italy, Scotland, and 
Sweden) have pushed for it (Colom et al.). Several barriers for 
implementing brief advice have been identified, including a risk 
of upsetting patients and a lack of time, training, and incentives 
(13). This is why a fair share of the current research on brief 
advice focusses on implementation science, seeking strategies to 
overcome these barriers.
FUtUrE liNES For BriEF adViCE
Facilitated access to e-health and m-health modules could 
potentially boost the implementation and coverage of brief 
advice, and a number of clinical trials are underway [Wallace 
and Bendtsen; (14, 15)]. Ambitious projects have already been 
carried out, such as the FP7 EU funded project ODHIN (www.
odhinproject.eu), which compared three strategies for promoting 
screening and brief advice activity in primary care (training and 
support, financial reimbursement, and referral to internet-based 
brief interventions), delivered separately or in combination. The 
ODHIN project showed the relevance of training and support 
and of financial incentives to increase the delivery rates of screen-
ing and brief advice but failed to find a significant impact of the 
option of referral to internet-based brief interventions1.
Despite the evidence of the effectiveness of brief advice, its 
uptake in Europe is very low (16). Several authors have recently 
proposed a new approach to improve dissemination of brief 
advice for heavy drinking in primary health care (17, 18). Rehm 
et al. propose a shift from the “prevention approach” to a more 
medical “treatment approach,” where alcohol problems should be 
managed with the same strategies and up to the same standards 
applied for other chronic conditions, such as high blood pressure 
and diabetes (19). According to this model, special attention 
should be paid to comorbid conditions such as hypertension, 
insomnia, liver problems, depression, and anxiety disorders, all 
of them very prevalent in primary health care.
In conclusion, despite strong evidence on the efficacy, effec-
tiveness, and cost-effectiveness of brief advice in primary health 
care, its implementation in Europe is still very low. Therefore, new 
approaches making the best use of new technologies and aiming 
for a medical management of risky and harmful and alcohol use 
in primary health care, with the same standards used for common 
chronic medical conditions, should be tested.
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